Religious Liberty Firm to Supreme Court: End this Assault on Little Sisters of the Poor, Religious Organizations
10 mars 2020 09h59 HE
|
First Liberty Institute
WASHINGTON, March 10, 2020 (GLOBE NEWSWIRE) -- First Liberty Institute filed a friend-of-the-court brief in Little Sisters of the Poor v. Pennsylvania urging the Supreme Court of the United States...
Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention
12 févr. 2019 09h00 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that researchers at the School of Pharmacy, Queen’s University...
Offrez d’abord des contraceptifs intra-utérins, conseillent les pédiatres
31 mai 2018 00h01 HE
|
Société canadienne de pédiatrie
OTTAWA, 31 mai 2018 (GLOBE NEWSWIRE) -- Selon un nouveau document de principes de la Société canadienne de pédiatrie, les contraceptifs intra-utérins devraient être proposés aux adolescentes avant...
Offer youth intrauterine methods of contraception first, paediatricians advise
31 mai 2018 00h01 HE
|
Canadian Paediatric Society
OTTAWA, May 31, 2018 (GLOBE NEWSWIRE) -- Intrauterine methods of contraception should be the first-line birth control option for youth, according to a new position statement from the Canadian...
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
14 mars 2018 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12 mars 2018 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months and year ended...
Agile Therapeutics Reports Third Quarter 2017 Financial Results
06 nov. 2017 16h20 HE
|
Agile Therapeutics, Inc.
Cash Expected to Fund Operations into Q2 2018 Prescription Drug User Fee Act (PDUFA) Goal Date for Twirla® is December 26, 2017 PRINCETON, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Agile...
Agile Therapeutics Inc. Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy
10 oct. 2017 18h38 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today hosted the Company’s first analyst day in New York City to showcase its...
Agile Therapeutics to Host First Analyst Day on October 10, 2017
02 oct. 2017 07h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday,...
Agile Therapeutics to Present Additional Phase 3 Data at the North American Forum on Family Planning Annual Meeting
28 sept. 2017 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract based on the Phase 3 SECURE trial of its...